[原著論文]
Atsumi T, Yamamoto K, Takeuchi T, Yamanaka H, Ishiguro N, Tanaka Y, Eguchi K,Watanabe A, Origasa H, Yasuda S, Yamanishi Y, Kita Y, Matsubara T, Iwamoto M, ShojiT, Okada T, van der Heijde D, Miyasaka N, Koike T. The first double-blind,randomised, parallel-group certolizumab pegol study in methotrexate-naive earlyrheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibitionof radiographic progression.

Ann Rheum Dis 75:75-83,2016

Tanaka Y, Mori H, Aoki T, Atsumi T, Kawahito Y, Nakayama H, Thoma S, Yamanishi Y,Hasegawa H, Tanimura K, Negoro N, Ueki Y, Kawakami A, Eguchi K, Saito K, Okada Y.
Analysis of bone metabolism during early stage and clinical benefits of earlyintervention with alendronate in patients with systemic rheumatic diseases treatedwith high-dose glucocorticoid: Early DIagnosis and Treatment of OsteopoRosis in Japan(EDITOR-J) study.

J Bone Miner Metab. 2015 Aug 26. [Epub ahead of print]

Yamanishi Y, Ito-Ihara T, Nagao T, Uno K, Kobayashi S, Muso E, Shane PY, Firestein
GS, Hashimoto H, Okazaki T, Suzuki K. Clinical features of patients with
anti-neutrophil cytoplasmic autoantibodies targeting native myeloperoxidase antigen.

Mod Rheumatol 23:963-71,2013

Ito-Ihara T, Muso E, Kobayashi S, Uno K, Tamura N, Yamanishi Y, Fukatsu A, Watts
RA, Scott DG, Jayne DR, Suzuki K, Hashimoto H. A comparative study of the diagnostic
accuracy of ELISA systems for the detection of anti-neutrophil cytoplasm antibodies
available in Japan and Europe.

Clin Exp Rheumatol. 6:1027-33,2008Yamanishi Y, Boyle DL, Green DR, Keystone EC, Connor A, Zollman S, Firestein
GS. p53 tumor suppressor gene mutations in fibroblast-like synoviocytes fromerosion synovium and non-erosion synovium in rheumatoid arthritis.

Arthritis Res Ther 7:R12-8,2005

Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, Mackman N, Haase
VH, Jaenisch R, Corr M, Nizet V, Firestein GS, Gerber HP, Ferrara N, Johnson
RS. HIF-1α is essential for myeloid cell-mediated inflammation.

Cell 112:645-57, 2003

Yamanishi Y, Boyle DL, Rosengren S, Green DR, Zvaifler NJ, Firestein GS.
Regional analysis of p53 mutations in rheumatoid arthritis synovium.

PNAS 99: 10025-30, 2002

Han Z, Chang L, Yamanishi Y, Karin M, Firestein GS.

Joint damage andinflammation in c-Jun N-terminal kinase 2 knockout mice with passive murine
collagen-induced arthritis.

Arthritis Rheum 46:818-23, 2002

Yamanishi Y, Boyle DL, Clark M, Maki RA, Tortorella MD, Arner EC, Firestein
GS. Expression and regulation of aggrecanase in arthritis: the role of TGF-beta.

J Immunol 168:1405-12, 2002

Yamanishi Y, Boyle DL, Pinkoski MJ, Mahboubi A, Lin T, Han Z, Zvaifler NJ,Green DR, Firestein GS. Regulation of Joint Destruction and Inflammation by
p53 in Collagen-Induced Arthritis.

Am J Pathol 160:123-30, 2002

Aupperle KR, Yamanishi Y, Bennett BL, Mercurio F, Boyle DL, Firestein GS.
Expression and regulation of inducible IkappaB kinase (IKK-i) in humanfibroblast-like synoviocytes.

Cell Immunol 214:54-9, 2001

Yamanishi Y, Ishioka S, Yamakido M.

Complete remission of relapsing

eosinophilic fasciitis associated with bronchial asthma following regularsteroid inhalation.

Rheumatology 39:339-340, 2000

Yamanishi Y, Hiyama K, Ishioka S, Maeda H, Yamanaka T, Kurose Y, Yamakido M.
Telomerase activity in the synovial tissues of chronic inflammatory andnon-inflammatory rheumatic diseases.

Int J Mol Med 4:513-517, 1999

Yamanishi Y, Maeda H, Hiyama K, Ishioka S, Yamakido M.

Dermatomyositis

associated with fatal rapidly progressive interstitial pneumonitis andpneumomediastinum.

Scand J Rheumatol 28:58-61,1999

Yamanishi Y, Hiyama K, Maeda H, Ishioka S, Murakami T, Hiyama E, Kurose Y,Shay JW, Yamakido.

Telomerase activity in rheumatoid synovium correlateswith the mononuclear cell infiltration level and disease aggressiveness ofrheumatoid arthritis.

J Rheumatol 25:214-220, 1998

Yamanishi Y, Maeda H, Hiyama K, Ishioka S, Yamakido M.
Rheumatoid arthritis associated with diffuse panbronchiolitis.

Intern Med 37:338-341, 1998